Obezitede Nonfarmakolojik Tedavi

Obezite, genetik, çevresel, biyolojik, sosyokültürel ve davranışsal faktörlerin bir araya gelerek ortaya çıkardığı, vücuttaki yağ dokusu kütlesinin artması ile tanımlanan, gerek oluşum nedenleri, gerekse oluşturduğu komplikasyonlar ve zemin hazırladığı hastalıklar nedeniyle kronik ve tekrarlayıcı bir hastalıktır. Obezite tedavisinde amaç, obeziteye ilişkin morbidite ve mortalite risklerini azaltmak, bireye yeterli ve dengeli beslenme alışkanlığı kazandırmak ve yaşam kalitesini yükseltmektir. Obezite tedavisinde vücut ağırlığının 6 aylık dönemde %10 azalması, obezitenin yol açtığı sağlık sorunlarının önlenmesinde önemli yarar sağlamaktadır.

Nonpharmacologic Treatment in Obesity

Obesity is defined as the increase of fat mass in the body, caused by genetic, environmental, biological, sociocultural and behavioral factors, and it is considered as a chronic and recurrent disease due to the causes of formation, the complications and the diseases it induces.The aim of obesity treat-ment is to decrease obesity related morbidity and mortality risks, to provide adequate and balanced nutrition habits and to improve quality of life. In obesity treatment, a 10% decrease in body weight over a six-month period provides important benefits in preventing obesity-induced health problems.

___

  • Türkiye Obezite (Şişmanlık) İle Mücadele ve Kontrol Programı (2010-2014), Sağlık Bakanlı-ğı Yayın No: 773, Kuban Matbaacılık Yayıncı-lık, Ankara, 2010.
  • Türkiye’ye Özgü Beslenme Rehberi, T.C. Sağ-lık Bakanlığı Temel Sağlık Hizmetleri Genel Müdürlüğü, Ankara, 2007.
  • Çoşkun A, Kesici C, Çelikcan E, Bilici S (Eds): Hastalıklarda Beslenme ve Obezite Bilgi Serisi, Sağlık Bakanlığı Yayın No: 733, Klasmat Mat-baacılık, Ankara, 2008.
  • Tsigos C, Hainer V, Basdevant A, et al. Mana-gement of obesity in adults: European Clinical Pratice Guidelines, Obesity Facts 2008; 1: 106-16.
  • Lau DCW, Douketis JD, Morrison KM, et al. 2006 Canadian Clinical Practice Guidelines on the management and prevention of obesity in adults and children. CMAJ 2007; 176: 1-13.
  • Stuart RB. Behavioral control of overeating. Behav Res Ther 1967; 5: 357-65.
  • Jeffery RW, Drewnowski A, Epstein LH, et al. Long-term maintenance of weight loss: current status. Health Psychol 2000; 19: 5-16.
  • Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 di-abetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
  • Perri MG, Nezu AM, McKelvey WF, et al. Relapse prevention training and problem-solving therapy in the long-term management of obesity. J Consult Clin Psychol 2001; 69: 722-6.
  • Wing RR. Behavioral approaches to the treat-ment of obesity. In: Bray GA, Bouchard C, eds. Handbook of Obesity: Clinical Applications. 2nd ed. New York: Marcel Dekker; 2004.
  • Bandura A, Simon KM. The role of proximal intentions in self-regulation of refractory beha-vior. Cognit Ther Res 1977; 1: 177-93.
  • Wing RR, Phelan S. Long-term weight loss maintenance. Am J Clin Nutr 2005; 82 (1 Suppl): 222-5.
  • McLean N, Griffin S, Toney K, et al. Family involvement in weight control, weight main-tenance and weight-loss interventions: a syste-matic review of randomised trials. Int J Obes Relat Metab Disord 2003; 27: 987-1005.
  • Avenell A, Broom J, Brown TJ, et al. Systema-tic review of the long-term effects and economic consequences of treatments for obesity and imp-lications for health improvement. Health Tech-nol Assess 2004; 8: 181-2.
  • Foster GD, Wadden TA, Vogt RA, et al. What is a reasonable weight loss? Patients' expectati-ons and evaluations of obesity treatment outco-mes. J Consult Clin Psychol 1997; 65: 79-85.
  • Katzel LI, Bleecker ER, Colman EG, et al. Ef-fects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men: a randomi-zed controlled trial. JAMA 1995; 274: 1915-21.
  • Kay SJ, Fiatarone Singh MA. The influence of physical activity on abdominal fat: a systematic review of the literature. Obes Rev 2006; 7: 183-200.
  • Ross R, Janssen I, Dawson J, et al. Exercise-induced reduction in obesity and insulin resis-tance in women: a randomized controlled trial. Obes Res 2004; 12: 789-98.
  • Jakicic JM. Exercise in the treatment of obesity. Endocrinol Metab Clin North Am 2003; 32: 967–80.
  • Fogelholm M, Kukkonen-Harjula K. Does phy-sical activity prevent weight gain? A systematic review. Obes Rev 2000; 1: 95-111.
  • Pate RR, Pratt M, Blair SN, et al. Physical acti-vity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA 1995; 273: 402-7.
  • Morris CJ, Yang JN, Scheer FA. The impact of the circadian timing system on cardiovascular and metabolic function. Prog Brain Res 2012; 199: 337-58.